Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-13

FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved the original application for rivastigmine tartrate from Nivagen Pharmaceuticals, Inc., establishing a generic version of rivastigmine tartrate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine tartrate (rivastigmine tartrate)

Snippet

ORIG AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)